CAS: 81131-70-6; (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8Ar)-6-Hydroxy-2-Methyl-8-(((S)-2-Methylbutanoyl)Oxy)-1,2,6,7,8,8A-Hexahydronaphthalen-1-yl)Heptanoic Acid, Sodium Salt

该化合物是一种可溶水,不饱和的抗水性非水性衍生物,它通过抑制HMG-CoA还原酶而表现出强大的胆固醇低温活动. 它的药用动力特征允许每天一次性下药,并减少与脂性溶性恒定素相比的有害影响风险,为管理高胆固醇提供了方便的治疗选择.

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

pravastatin mevastatin 3β-hydroxy ML-236B methylester 3β-hydroxy ML-236Blactone form of C-6 epimer of pravastatin pravastatin pravastatin lactone R-195

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7301006-B2
    优先权日:2002-07-16
    标 题 :Methods and materials for the synthesis of modified peptides
    发明人:YOUNG TRAVIS G; KIESSLING LAURA L
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:Methods and protected amino acids useful as building blocks (protected monomers) for the synthesis of peptides and proteins that are selectively modified at one or more side-chain hydroxyl groups. Azide-bearing protecting groups allow the selective deprotection of side-chain hydroxyl groups of amino acids after synthesis of a peptide. Reaction conditions for removal of the azide-bearing protecting group can be selected which are substantially orthogonal to those that will remove α-amino protecting groups typically employed in peptide synthesis, such that hydroxyl groups protected with the azide-bearing protecting group remain protected during synthesis of the peptide chain. Various protecting groups which are readily available can be used for protecting potentially reactive side chain groups of amino acids in the peptide or protein to be modified. Preferred side-chain protecting groups are chemically distinguishable from the azide-bearing protecting group and substantially orthogonal reaction conditions can be selected such that side-chain protection of other amino acids is maintained when the azide-bearing protecting group is removed. The use of the azide-bearing protecting group of this invention for one or more hydroxy amino acids during peptide synthesis allows the selective unmasking of those azide-protected side-chain hydroxyl groups and selective modification of the hydroxyl groups that are selectively unmasked. The methods and materials herein are particularly used in synthesis of sulfated, phosphorylated and glycosylated peptides and proteins. Kits and methods of synthesizing a modified peptide or protein using the kits are also provided.

    专利号:US-5374541-A
    优先权日:1993-05-04
    标 题 :Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
    发明人:WONG CHI-HUEY; GAETA FEDERICO C A
    权利人:SCRIPPS RESEARCH INST; CYTEL CORP
    摘要:A single reaction vessel process for the synthesis of a sialylated galactoside is disclosed. The synthesis utilizes a β-galactosidase to catalyze the reaction of a galactose-containing substrate and an acceptor to form a new galactosyl glycoside that is then sialylated using a cyclic multienzyme synthesis system to form CMP-sialic acid that sialylates the formed galactosyl glycoside in the presence of an α-sialyltransferase. The value of K m /V max for the formed galactosyl glycoside as a substrate for the α-sialyltransferase is less than one-third the K m /V max value for the galactose-containing substrate for that α-sialyltransferase.

    专利号:US-6579725-B1
    优先权日:1999-03-05
    标题 :Linkers for synthesis of oligosaccharides on solid supports
    发明人:SEEBERGER PETER H; ANDRADE RODRIGO B
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The present invention relates to versatile linkers for tethering a molecule to a solid support, e.g., for tethering a monomer, oligomer or polymer to a solid support, which are stable to a wide range of reaction conditions, but can be cleaved under well-defined conditions, thereby liberating the molecule from the solid support. Preferably, the linkers are used to tether to the solid support unprotected, partially-protected or fully-protected monosaccharides or oligosaccharides, or unprotected, partially-protected or fully-protected glycoconjugates. The linkers of the present invention may be used to tether to solid supports building blocks useful in the assembly of libraries of other types of small molecules. The present invention also relates to a molecule or plurality of molecules tethered to the solid support via a linker or linkers of the present invention. The present invention also relates to processes for synthesizing molecules, e.g., monomers, oligomers or polymers, on a solid support, wherein a starting material in the synthesis of the molecule, intermediates in the synthesis of the molecule, and the molecule itself are tethered to the solid support during the process via one of the linkers of the present invention. In certain processes of the present invention, the molecule is liberated from the solid support by cleavage of the linker of the present invention.

    专利号:US-5856143-A
    优先权日:1993-05-14
    标 题 :N-containing saccharides and method for the synthesis of N-containing saccharides from amino-deoxy-disaccharides and amino-deoxy-oligosaccharides
    发明人:NILSSON KURT G I
    权利人:BIOFLEXIN AB
    摘要:Synthesis of an amino-disaccharide, amino-oligosaccharide or a derivative thereof, characterized in that a monosaccharide, a disaccharide, an oligosaccharide, a glycoside or a derivative thereof, in the presence of a glycosidase as catalyst, is reacted with an amino-deoxy-saccharide or a derivative thereof, and that the amino-saccharide is isolated from the product mixture directly or after chemical/enzymatic modification.

    专利号:US-6846917-B2
    优先权日:2001-01-23
    标题:Solid- and solution-phase synthesis of heparin and other glycosaminoglycans
    发明人:SEEBERGER PETER H; ORGUEIRA HERNAN; SCHELL PETER
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Described is a modular, general synthetic strategy for the preparation in solution and on a solid support of heparin, heparin-like glycosaminoglycans, glycosaminoglycans and non-natural analogs of each of them. Additionally, the modular strategy provides the basis for the preparation of combinatorial libraries and parallel libraries of defined glycosaminoglycan oligosaccharides. The defined glycosaminoglycan structures may be used in high-throughput screening experiments to identify carbohydrate sequences that regulate a host of recognition and signal-transduction processes. The determination of specific sequences involved in receptor binding holds great promise for the development of molecular tools which will allow modulation of processes underlying viral entry, angiogenesis, kidney diseases and diseases of the central nervous system. Notably, the present invention enables the automated synthesis of glycosaminoglycans in much the same fashion that peptides and oligonucleotides are currently assembled.

    专利号:WO-9508553-A1
    优先权日:1993-09-22
    标 题 :Synthesis of selectin ligands
    发明人:NICOLAOU K C; BOCKOVICH NICHOLAS J; CARCANAGUE DANIEL R
    权利人:SCRIPPS RESEARCH INST; NICOLAOU K C; BOCKOVICH NICHOLAS J; CARCANAGUE DANIEL R
    摘要:The total synthesis of the naturally occurring sulfated Le?x and Lea¿ tetrasaccharides, trisaccharide analogs of sulfated Le?x and Lea¿, and multivalent Lex selectin ligands are described.
    诚和国际有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.maytime.com.cn
    电话: 86-571-88925295 88920965👤
    📞诚和国际有限公司 ⚠️参考联系方式

    销售电话:86-571-88925295 88920965
    邮箱:sales@maytime.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北猫尔沃生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.marvel-bio.com
    电话:027-87738651👤
    📞 湖北猫尔沃生物医药有限公司⚠️参考联系方式

    电话: 027-87738651
    邮件:sales@marvel-bio.com
    网址: http://www.marvel-bio.com
    地址:湖北省高新技术开发区关山大道
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    湖北省高新技术开发区关山大道
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    郑州佰宇药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zzbaiyu.com
    企业联系电话:13938569199👤
    📞郑州佰宇药业有限公司 ⚠️参考联系方式
    联系人:陈经理
    电话:13938569199


    邮箱:13938569199@163.com
    通信地址: 河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
    邮编: 450000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河南省郑州市新郑市龙湖镇小刘桥百鸿机电市场C3区22号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北威德利化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.widelychemical.com
    企业联系电话:13385289472👤
    📞湖北威德利化学科技有限公司 ⚠️参考联系方式
    联系人:赵方
    电话:13385289472
    手机:13385289472
    传真:027- 59222918
    邮箱:z13385289472@163.com
    通信地址: 湖北省武汉市硚口区解放大道204号
    邮编: 430033
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市硚口区解放大道204号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Liu JH, Tian YY, Zhao XY, Li YL, Lyu YN, Liu C, Lin ZZ, Wang ZJ, Zuo ZP, Wang ZB. [Research on mechanism of hypolipidemic effect of Massa Medicata Fermentata based on metabolomics]. Zhongguo Zhong Yao Za Zhi. 2024 Feb;49(3):770-778. Chinese. doi: 10.19540/j.cnki.cjcmm.20231019.401. 12(1):32. doi: 10.3390/pharmacy12010032.
    3: Elsayed SI, El-Dahan MS, Girgis GNS. Pharmacodynamic Studies of Pravastatin Sodium Nanoemulsion Loaded Transdermal Patch for Treatment of Hyperlipidemia. AAPS PharmSciTech. 2024 Feb 8;25(2):34. doi: 10.1208/s12249-024-02746-5. 15(3):925. doi: 10.3390/pharmaceutics15030925.
    5: Maehara Y, Oki E, Ota M, Harimoto N, Ando K, Nakanishi R, Kawazoe T, Fujimoto Y, Nonaka K, Kitao H, Iimori M, Makino K, Takechi T, Sagara T, Miyadera K, Matsuoka K, Tsukihara H, Kataoka Y, Wakasa T, Ochiiwa H, Kamahori Y, Tokunaga E, Saeki H, Yoshizumi T, Kakeji Y, Shirabe K, Baba H, Shimada M. Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii. Int J Clin Oncol. 2023 May;28(5):613-624. doi: 10.1007/s10147-023-02326-w. Epub 2023 Mar 24.

    合成参考文献


    参考文献:10.1124/jpet.105.084830
    摘要:Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y. Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin. The Journal of Pharmacology and Experimental Therapeutics. 2005 Aug;314(2):876–82. doi: 10.1124/jpet.105.084830.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知